Chromatic and flicker threshold changes in age-related macular degeneration following anti-VEGF treatment

References

• Jackson GR, Curcio CA, Sloan KR, et al. Photoreceptor degeneration in aging and age-related maculopathy. In: Penfold  PL, Provis  JM, editors. Macular degeneration. New York: NY Springer Publishing Co Inc; 2005. p. 45–62.
   Google Scholar
• Yu D-Y, Cringle SJ. Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease. Prog Retin Eye Res. 2001;20:175–208.
   PubMed Web of Science ®Google Scholar
• Blasiak J, Petrovski G, Veréb Z, et al. Oxidative stress, hypoxia, and autophagy in the neovascular processes of age-related macular degeneration. Biomed Res Int. 2014;2014:1–7.
   Web of Science ®Google Scholar
• Feigl B. Age-related maculopathy in the light of ischaemia. Clin Exp Optom. 2007;90:263–271.
   PubMed Web of Science ®Google Scholar
• Feigl B, Brown B, Lovie-Kitchin J, et al. Functional loss in early age-related maculopathy: the ischaemia postreceptoral hypothesis. Eye. 2007;21:689–696.
   PubMed Web of Science ®Google Scholar
• Feigl B. Age-related maculopathy–linking aetiology and pathophysiological changes to the ischaemia hypothesis. Prog Retin Eye Res. 2009;28:63–86.
   PubMed Web of Science ®Google Scholar
• Yonekawa Y, Miller JW, Kim IK. Age-related macular degeneration: advances in management and diagnosis. J Clin Med. 2015;4:343–359.
   PubMed Web of Science ®Google Scholar
• Amoaku W, Balaskas K, Cudrnak T, et al. Initiation and maintenance of a treat-and-extend regimen for ranibizumab therapy in wet age-related macular degeneration: recommendations from the UK retinal outcomes group. Clin Ophthalmol. 2018;12:1731.
   PubMed Web of Science ®Google Scholar
• Dimitrov PN, Robman LD, Varsamidis M, et al. Visual function tests as potential biomarkers in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;52:9457–9469.
   PubMed Web of Science ®Google Scholar
• Feigl B, Cao D, Morris CP, et al. Persons with age-related maculopathy risk genotypes and clinically normal eyes have reduced mesopic vision. Invest Opthalmol Visual Sci. 2011;52:1145–1150.
   PubMed Web of Science ®Google Scholar
• Robinson DG, Margrain TH, Bailey C, et al. An evaluation of a battery of functional and structural tests as predictors of likely risk of progression of age-related macular degeneration. Invest Opthalmol Visual Sci. 2019;60:580–589.
   PubMed Web of Science ®Google Scholar
• Ziemssen F, Lüke M, Messias A, et al. Safety monitoring in bevacizumab (Avastin) treatment: retinal function assessed by psychophysical (visual fields, colour vision) and electrophysiological (ERG/EOG) tests in two subgroups of patients. Int Ophthalmol. 2008;28:101–109.
   PubMedGoogle Scholar
• Zuo C, Wen F, Li J, et al. Functional changes following combined intravitreal bevacizumab and photodynamic therapy for polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol. 2010;248:191–196.
   PubMed Web of Science ®Google Scholar
• Vemala R, Sivaprasad S, Barbur JL. Detection of early loss of color vision in age-related macular degeneration – with emphasis on drusen and reticular pseudodrusen. Invest Opthalmol Visual Sci. 2017;58:BIO247–BIO254.
   PubMed Web of Science ®Google Scholar
• Abdel-Hay A, Sivaprasad S, Subramanian A, et al. Acuity and colour vision changes post intravitreal dexamethasone implant injection in patients with diabetic macular oedema. PLoS One. 2018;13:e0199693.
   PubMed Web of Science ®Google Scholar
• Ferris III FL, Wilkinson C, Bird A, et al. Clinical classification of age-related macular degeneration. Ophthalmology. 2013;120:844–851.
   PubMed Web of Science ®Google Scholar
• Chylack LT, Wolfe JK, Singer DM, et al. The lens opacities classification system III. Arch Ophtalmol. 1993;111:831–836.
   PubMed Web of Science ®Google Scholar
• Holekamp NM. Review of neovascular age-related macular degeneration treatment options. Am J Manage Care. 2019;25:S172–S181.
   PubMed Web of Science ®Google Scholar
• Laidlaw DAH, Tailor V, Shah N, et al. Validation of a computerised logMAR visual acuity measurement system (COMPlog): comparison with ETDRS and the electronic ETDRS testing algorithm in adults and amblyopic children. Br J Ophthalmol. 2008;92:241–244.
   PubMed Web of Science ®Google Scholar
• Bi W, Gillespie-Gallery H, Binns A, et al. Flicker sensitivity in normal aging—monocular tests of retinal function at photopic and mesopic light levels. Invest Opthalmol Visual Sci. 2016;57:387–395.
   PubMed Web of Science ®Google Scholar
• Hathibelagal AR, Bharadwaj SR, Yadav AR, et al. Age-related change in flicker thresholds with rod- and cone-enhanced stimuli. PLoS One. 2020;15:e0232784.
   PubMed Web of Science ®Google Scholar
• Phipps JA, Dang TM, Vingrys AJ, et al. Flicker perimetry losses in age-related macular degeneration. Invest Opthalmol Visual Sci. 2004;45:3355–3360.
   PubMed Web of Science ®Google Scholar
• Barbur JL, Rodriguez-Carmona M, Harlow A. Establishing the statistical limits of “normal” chromatic sensitivity. CIE Expert Symposium, CIE Proceedings 75 Years of the Standard Colorimetric Observer; 2006.
   Google Scholar
• Barbur JL, Rodriguez-Carmona M. Color vision changes in normal aging. In: Elliott AJ, Fairchild MD, Franklin A, editors. Handbook of color psychology. Cambridge, Ottawa: Cambridge University Press; 2015. p. 180–196.
   Google Scholar
• Barbur JL, Rodriguez-Carmona M. Variability in normal and defective colour vision: consequences for occupational environments. In: Best J, editor. Colour design. Cambridge: Woodhead Publishing Limited; 2012. p. 24–82.
   Google Scholar
• Seshadri J, Christensen J, Lakshminarayanan V, et al. Evaluation of the new web-based “colour assessment and diagnosis” test. Optom Vis Sci. 2005;82:882–885.
   PubMed Web of Science ®Google Scholar
• Bokinni Y, Shah N, Maguire O, et al. Performance of a computerised visual acuity measurement device in subjects with age-related macular degeneration: comparison with gold standard ETDRS chart measurements. Eye. 2015;29:1085–1091.
   PubMed Web of Science ®Google Scholar
• Hathibelagal AR, Mulani Y, Dave VP. Visual function deficits in eyes with resolved endophthalmitis. Sci Rep. 2021;11:2285.
   PubMed Web of Science ®Google Scholar
• Guymer RH, Brassington KH, Dimitrov P, et al. Nanosecond-laser application in intermediate AMD: 12-month results of fundus appearance and macular function. Clin Exp Ophthalmol. 2014;42:466–479.
   PubMed Web of Science ®Google Scholar
• Mones J, Rubin G. Contrast sensitivity as an outcome measure in patients with subfoveal choroidal neovascularisation due to age-related macular degeneration. Eye. 2005;19:1142–1150.
   PubMed Web of Science ®Google Scholar
• Nixon DR, Flinn NA. Evaluation of contrast sensitivity and other visual function outcomes in neovascular age-related macular degeneration patients after treatment switch to aflibercept from ranibizumab. Clin Ophthalmol. 2017;11:715.
   PubMed Web of Science ®Google Scholar
• Hathibelagal AR, Bharadwaj SR, Jalali S, et al. Evaluation of photoreceptor function in inherited retinal diseases using rod- and cone-enhanced flicker stimuli. Ophthalmic Physiol Opt. 2021. in Press. https://doi.org/10.1111/opo.12799
   PubMed Web of Science ®Google Scholar
• Curcio CA, Owsley C, Jackson GR. Spare the rods, save the cones in aging and age-related maculopathy. Invest Ophthalmol Visual Sci. 2000;41:2015–2018.
   PubMed Web of Science ®Google Scholar
• Dimopoulos IS, Tennant M, Johnson A, et al. Subjects with unilateral neovascular AMD have bilateral delays in rod-mediated phototransduction activation kinetics and in dark adaptation recovery. Invest Opthalmol Visual Sci. 2013;54:5186–5195.
   PubMed Web of Science ®Google Scholar
• Spraul CW, Lang GE, Grossniklaus HE, et al. Histologic and morphometric analysis of the choroid, Bruch’s membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes. Surv Ophthalmol. 1999;44:S10–S32.
   PubMed Web of Science ®Google Scholar
• Boycott B, Wässle H. Morphological classification of bipolar cells of the primate retina. Eur J Neurosci. 1991;3:1069–1088.
   PubMed Web of Science ®Google Scholar
• Ferraz D, Bressanim G, Takahashi B, et al. Three-monthly intravitreal bevacizumab injections for neovascular age-related macular degeneration: short-term visual acuity results. Eur J Ophthalmol. 2010;20:740–744.
   PubMed Web of Science ®Google Scholar
• Iwata E, Ueno S, Ishikawa K, et al. Focal macular electroretinograms after intravitreal injections of bevacizumab for age-related macular degeneration. Invest Opthalmol Visual Sci. 2012;53:4185–4190.
   PubMed Web of Science ®Google Scholar
• Ying G-S, Huang J, Maguire MG, et al. Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration. Ophthalmology. 2013;120:122–129.
   PubMed Web of Science ®Google Scholar
• Wu Z, Cunefare D, Chiu E, et al. Longitudinal associations between microstructural changes and microperimetry in the early stages of age-related macular degeneration. Invest Opthalmol Visual Sci. 2016;57:3714–3722.
   PubMed Web of Science ®Google Scholar
• Finger RP, Daien V, Eldem BM, et al. Anti-vascular endothelial growth factor in neovascular age-related macular degeneration – a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems. BMC Ophthalmol. 2020;20:294.
   PubMed Web of Science ®Google Scholar
• Inoue M, Arakawa A, Yamane S, et al. Intravitreal injection of ranibizumab using a pro re nata regimen for age-related macular degeneration and vision-related quality of life. Clin Ophthalmol. 2014;8:1711–1716.
   PubMedGoogle Scholar
• Paulus YM, Jefferys JL, Hawkins BS, et al. Visual function quality of life measure changes upon conversion to neovascular age-related macular degeneration in second eyes. Qual Life Res. 2017;26:2139–2151.
   PubMed Web of Science ®Google Scholar
• Thetford C, Hodge S, Harding S, et al. Living with age-related macular degeneration treatment: patient experiences of being treated with ranibizumab (Lucentis)(R) intravitreal injections. Br J Vis Impair. 2013;31:89–101.
   Google Scholar
• Hirvelä H, Koskela P, Laatikainen L. Visual acuity and contrast sensitivity in the elderly. Acta Ophthalmol Scand. 2009;73:111–115.
   Google Scholar
• Pradhan ZS, Abraham L., Braganza A. Determinants of macular thickness in normal Indian eyes. J Clin Ophthalmol Res. 2013;1:11.
   Google Scholar